Concepedia

Stephen Lim

SL

16

Publications

577

Citations

12

H-Index

2000

Active since

Affiliations

Cedars-Sinai Medical Center(Current)

Institute for Myeloma & Bone Cancer Research

Novartis (United States)

Oncotherapeutics (United States)

Novartis (India)

Stephen Lim is an author at Cedars-Sinai Medical Center specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

2000–2023

16

Publications

16

Temozolomide: a novel treatment for pituitary carcinoma

Stephen Lim, Hrayr K. Shahinian, Menahem M. Maya et al. · The Lancet Oncology · 2006 · 176 citations

, , +4

Kymriah® (tisagenlecleucel) – An overview of the clinical development journey of the first approved CAR-T therapy

Rakesh Awasthi, Harald J. Maier, Jie Zhang et al. · Human Vaccines & Immunotherapeutics · 2023 · 83 citations · Full text

, , +19

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors

Odelia Cooper, Adam N. Mamelak, Serguei Bannykh et al. · Endocrine · 2013 · 81 citations · Full text

, , +8

Rituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria

Ahrin Koppel, Stephen Lim, Melanie Osby et al. · Transfusion · 2007 · 42 citations

A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple Myeloma

James R. Berenson, Jennifer To, Tanya M. Spektor et al. · Clinical Cancer Research · 2020 · 35 citations

Rows per page

1–5 of 16